Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -0.19% vs 0.28% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -9.11% vs -8.98% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -8.36% vs 3.26% in Mar 2025
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
8.76
1.17
13.36%
Share Warrants & Outstandings
Total Reserve
-25.07
6.05
-31.12
-514.38%
Shareholder's Funds
-15.15
14.81
-29.96
-202.30%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.51
0.00
18.51
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.51
0.00
18.51
0.00%
Deferred Tax Assets / Liabilities
-0.90
-0.02
-0.88
-4,400.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.01
-0.01
-100.00%
Total Non-Current Liabilities
17.61
-0.01
17.62
176,200.00%
Current Liabilities
Trade Payables
2.62
0.37
2.25
608.11%
Other Current Liabilities
1.16
0.22
0.94
427.27%
Short Term Borrowings
3.02
0.01
3.01
30,100.00%
Short Term Provisions
2.72
0.00
2.72
0.00%
Total Current Liabilities
9.53
0.60
8.93
1,488.33%
Total Liabilities
11.99
15.40
-3.41
-22.14%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.77
1.41
26.36
1,869.50%
Less: Accumulated Depreciation
22.98
1.29
21.69
1,681.40%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
4.79
0.12
4.67
3,891.67%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
0.00
0.01
0.00%
Long Term Loans & Advances
1.38
0.73
0.65
89.04%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
6.17
0.85
5.32
625.88%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
3.98
2.40
1.58
65.83%
Sundry Debtors
1.17
9.27
-8.10
-87.38%
Cash and Bank
0.02
0.77
-0.75
-97.40%
Other Current Assets
0.63
0.04
0.59
1,475.00%
Short Term Loans and Advances
0.00
2.09
-2.09
-100.00%
Total Current Assets
5.81
14.56
-8.75
-60.10%
Net Current Assets (Including Current Investments)
-3.71
13.96
-17.67
-126.58%
Total Current Assets Excluding Current Investments
5.81
14.56
-8.75
-60.10%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
11.99
15.40
-3.41
-22.14%
Contingent Liabilities
1.33
0.54
0.79
146.30%
Total Debt
21.54
0.01
21.53
215,300.00%
Book Value per share (adjusted)
-15.26
1.69
-16.95
-1,002.96%
Annual - Borrowings
Borrowings 21.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -0.19% vs 0.28% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 4.79 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -9.11% vs -8.98% in Mar 2025
Annual - Investments
Investments 0.01 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 5.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.36% vs 3.26% in Mar 2025